N-hydroxy-3-(3,4-dihydro-4-oxo-6-phenethyl-2-pyrimidinylthio)propanamide

ID: ALA214877

Chembl Id: CHEMBL214877

PubChem CID: 135541974

Max Phase: Preclinical

Molecular Formula: C15H17N3O3S

Molecular Weight: 319.39

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CCSc1nc(O)cc(CCc2ccccc2)n1)NO

Standard InChI:  InChI=1S/C15H17N3O3S/c19-13(18-21)8-9-22-15-16-12(10-14(20)17-15)7-6-11-4-2-1-3-5-11/h1-5,10,21H,6-9H2,(H,18,19)(H,16,17,20)

Standard InChI Key:  QRAKIBWWWHOJPB-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA214877

    ---

Associated Targets(non-human)

hda106 Histone deacetylase HD2 (351 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
hd1b Histone deacetylase HD1B (86 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 319.39Molecular Weight (Monoisotopic): 319.0991AlogP: 1.96#Rotatable Bonds: 7
Polar Surface Area: 95.34Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 8.90CX Basic pKa: 1.67CX LogP: 2.86CX LogD: 2.85
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.31Np Likeness Score: -1.31

References

1. Mai A, Massa S, Rotili D, Simeoni S, Ragno R, Botta G, Nebbioso A, Miceli M, Altucci L, Brosch G..  (2006)  Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors.,  49  (20): [PMID:17004718] [10.1021/jm0605536]

Source